The First Affiliated Hospital of Wenzhou Medical University is a grade 3A hospital located in Wenzhou, Zhejiang, China. It is also recognised as the First Provincial Wenzhou Hospital of Zhejiang.

During the past decade, The First Affiliated Hospital of Wenzhou Medical University conducted 129 clinical trials. In the 10-year time frame, 129 clinical trials started and 17 clinical trials were completed, i.e. on average, 13.2% percent of trials that started reached the finish line to date. In the past 5 years, 78 clinical trials started and 12 clinical trials were completed. i.e. 15.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The First Affiliated Hospital of Wenzhou Medical University" #1 sponsor was "Janssen Research & Development, LLC" with 11 trials, followed by "First Affiliated Hospital of Wenzhou Medical University" with 10 trials sponsored, "Pfizer" with 10 trials sponsored, "Second Affiliated Hospital, School of Medicine, Zhejiang University" with 7 trials sponsored and "Wenzhou Medical University" with 7 trials sponsored. Other sponsors include 110 different institutions and companies that sponsored additional 76 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The First Affiliated Hospital of Wenzhou Medical University" #1 collaborator was "First Affiliated Hospital of Wenzhou Medical University" with 13 trials as a collaborator, "Peking University First Hospital" with 6 trials as a collaborator, "Shanghai Zhongshan Hospital" with 6 trials as a collaborator, "Sir Run Run Shaw Hospital" with 5 trials as a collaborator and "Beijing Tiantan Hospital" with 4 trials as a collaborator. Other collaborators include 319 different institutions and companies that were collaborators in the rest 212 trials.

According to Clinical.Site data, the most researched conditions in "The First Affiliated Hospital of Wenzhou Medical University" are "Chronic Hepatitis B" (8 trials), "Hepatitis B, Chronic" (5 trials), "Multiple Myeloma" (5 trials), "Alzheimer Disease" (3 trials) and "Coronary Artery Disease" (3 trials). Many other conditions were trialed in "The First Affiliated Hospital of Wenzhou Medical University" in a lesser frequency.

Most popular intervention types in "The First Affiliated Hospital of Wenzhou Medical University" are "Drug" (120 trials), "Other" (13 trials), "Device" (12 trials), "Procedure" (10 trials) and "Biological" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (27 trials), "placebo" (6 trials), "Tislelizumab" (5 trials), "Cyclophosphamide" (4 trials) and "Daratumumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "The First Affiliated Hospital of Wenzhou Medical University" are 137 trials for "All" genders, 14 trials for "Male" genders and 9 trials for "Female" genders.

Currently, there are 86 active trials in "The First Affiliated Hospital of Wenzhou Medical University". 2 are not yet recruiting, 57 are recruiting, 25 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 39 completed trials in The First Affiliated Hospital of Wenzhou Medical University, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in The First Affiliated Hospital of Wenzhou Medical University, 7 "Phase 1" clinical trials were conducted, 39 "Phase 2" clinical trials and 68 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 23 trials that are defined as “Not Applicable".